Comparison of Uroplakin Expression During Urothelial Carcinogenesis Induced by N-Butyl-N-(4-Hydroxybutyl)Nitrosamine in Rats and Mice

Abstract

The expression of uroplakins, the tissue-specific and differentiation-dependent membrane proteins of the urothelium, was analyzed immunohistochemically in N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-treated rats and mice during bladder carcinogenesis. Male Fischer 344 rats were treated with 0.05% BBN in the drinking water for 10 wk and were euthanatized at week 20 of the experiment. BBN was administered to male B6D2F₁ mice; it was either provided at a rate of 0.05% in the drinking water (for 26 wk) or 5 mg BBN was administered by intragastric gavage twice weekly for 10 wk, followed by 20 wk without treatment. In rats, BBN-induced, noninvasive, low-grade, papillary, transitional cell carcinoma (TCC) showed decreased uroplakin-staining of cells lining the lumen but showed increased expression in some nonluminal cells. In mice, nonpapillary, high-grade dysplasia, carcinoma in situ, and invasive carcinoma were induced. There was a marked decrease in the number of uroplakin-positive cells lining the lumen and in nonluminal cells. This occurred in normal-appearing urothelium in BBN-treated mice and in dysplasic urothelium, in carcinoma in situ, and in invasive TCC. The percentage of uroplakin-positive nonluminal cells was higher in control mice than in rats, but it was lower in the mouse than in the rat after BBN treatment. Uroplakin expression was disorderly and focal in BBN-treated urothelium in both species. These results indicate that BBN treatment changed the expression of uroplakins during bladder carcinogenesis, with differences in rats and mice being related to degree of tumor differentiation.

Keywords

Uroplakins differentiation bladder cancer cell membranes

References

Arai M. , Kani T. , Sugihara S. , Matsumura K. , Miyata Y. , Shinohara Y. , and Ito N. (1974). Scanning and transmission electron microscopy of changes in the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine . Gann 65: 529-540.

Becci PJ , Thompson HJ , Strum JM , Brown CC , Sporn MB , and Moon RC (1981). N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res. 41: 927-932.

Cohen SM (1983). Pathology of experimental bladder cancer in rodents . In: The Pathology of Bladder Cancer, Vol. 2, GT Bryan and SM Cohen (eds), CRC Press, Boca Raton, Florida, pp. 1-40.

Cohen SM , Ellwein LB , Okamura T. , Masui T. , Johansson SL , Smith RA , Wehner JM , Khachab M. , Chappel CI , Schoenig GP , Emerson JL , and Garland EM (1991). Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats . Cancer Res. 51: 1766-1777.

Ertürk E. , Cohen SM , and Bryan GT (1970). Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in female Swiss mice. Cancer Res. 30: 1309-1311.

Ertürk E. , Price JM , Morris Je , Cohen S , Leith Rs , Von Esch Am , and Crovetti AJ (1967). The production of carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res. 27: 1998-2002.

Hsu SM , Raine L. , and Fanger H. (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-580.

Ito N. , Hiasa Y. , Tamai A. , Okajima E. , and Kitamura H. (1969). Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann 60: 401-410.

Jacobs JB , Arai M. , Cohen SM , and Friedell GH (1976). Early lesions in experimental bladder cancer: Scanning electron microscopy of cell surface markers. Cancer Res. 36: 2512-2517.

10.

Lin J-H. , Wu X-R. , Kreibich G. , and Sun T-T. (1994). Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane. J. Biol. Chem. 269: 1775-1784.

11.

Lin J-H. , Zhao H. , and Sun T-T. (1995). A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. Proc. Natl. Acad. Sci. USA 92: 679-683.

12.

Martin RA , Daly AM , Difonzo CJ , and de la Iglesia FA (1984). Randomization of animals by computer program for toxicity studies. J. Am. Coll. Toxicol. 3: 1-11.

13.

Ogawa K. , Sun T-T. , and Cohen SM (1996). Analysis of differentiation associated proteins in rat bladder carcinogenesis. Carcinogenesis 17: 961-965.

14.

SAS Institute, Inc. (1989 ). SAS/STAT User's Guide, version 6, Vol. 2, 4th ed. SAS Institute, Inc. , Cary, North Carolina.

15.

Walz T. , Häner M. , Wu X-R. Henn C. , Engel A. , Sun T-T. , and Aebi U. (1995). Towards the molecular architecture of the asymmetric unit membrane of the mammalian urinary bladder epithelium: A closed "twisted ribbon" structure. J. Mol. Biol. 248: 887-900.

16.

Wu X-R. , Lin J-H. , Walz T. , Häner M. , Yu J. , Aebi U. , and Sun T-T. (1994). Mammalian uroplakins; A group of highly conserved urothelial differentiation-related membrane proteins . J. Biol. Chem. 269: 13716-13724.

17.

Wu X-R. , Manabe M. , Yu J. , and Sun T-T. (1990). Large scale purification and immunolocalization of bovine uroplakins I, II and III. J. Biol. Chem. 265: 19170-19179.

18.

Wu X-R. and Sun T-T. (1993). Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J. Cell Sci. 106: 31-43.

19.

Yu J. , Lin J-H. , Wu X-R. , and Sun T-T. (1994). Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J. Cell Biol. 125: 171-182.

20.

Yu J. , Manabe M. , Wu X-R. , Xu C. , Surya B. , and Sun T-T. (1990). Uroplakin I: A 27-kDa protein associated with the asymmetric unit membrane of mammalian urothelium. J. Cell Biol. 111: 1207-1216.